Daxor Announces That the University of Maryland Medical Center, Baltimore, Maryland, to Begin Heart Failure Treatment Research Utilizing Daxor's BVA-100 Blood Volume Analyzer
Posted on: Wednesday, 3 August 2005, 09:01 CDT
Daxor Corporation DXR, a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the University of Maryland Medical Center in Baltimore, Maryland.
Founded in 1823 as the Baltimore Infirmary, the University of Maryland Medical Center (UMMC) is one of the nation's oldest teaching hospitals. Located on the west side of downtown Baltimore, the Medical Center provides highly specialized tertiary and quaternary care for the entire state and region and comprehensive care for the West Baltimore community.
Dr. Stephen S. Gottlieb, M.D., UMMC Heart Failure Service Director, stated, "We hope that the BVA-100 will help us to determine how better to treat CHF patients."
All of University of Maryland Medical Center's doctors are faculty members at the University of Maryland School of Medicine, the nation's fifth oldest medical school that is a recognized leader in biomedical research and medical education. The Medical Center cares for more than 30,000 inpatients and 200,000 outpatients each year, and has many world-renowned specialized programs.
Derangement of a patient's blood volume is a prime disturbance in congestive heart failure patients. Physicians treating these patients are faced with a difficult dilemma in treating these patients with the optimum combination of diuretics and vasodilators. Recent published studies in Circulation and the American Journal of Cardiology from cardiologists utilizing the blood volume analyzer, have demonstrated the importance of correcting a patient's blood volume as well as treating hidden anemia, which is a common problem in heart failure. The BVA-100 Blood Volume Analyzer is a tool that enables a physician to treat congestive heart failure patients with a significantly improved degree of precision.
Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. Among nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a trial basis are The Mayo Clinic, The Cleveland Clinic and New York University Medical Center. The BVA-100 measures blood volume to within a 98% accuracy. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com.
Source: Business Wire
Related Articles
- Inverness Medical Launches Portable Blood Testing Monitor to Warn Patients and Their Physicians of Potential Blood Clots
- Daxor Announces Westchester Medical Center of Valhalla, NY Purchases Blood Volume Analyzer BVA-100
- Daxor Announces St. Francis Hospital of Wilmington, DE Purchases Blood Volume Analyzer BVA-100
- Daxor Announces Virginia Commonwealth University Medical Center of Richmond, VA Acquires Blood Volume Analyzer BVA-100
- Daxor Announces NorthCrest Medical Center of Springfield, TN Acquires Blood Volume Analyzer BVA-100
- A Major Study Compares Direct Blood Volume Measurement Using the BVA-100 With the BNP Test for Managing Fluid Therapy in the Intensive Care Unit
- Daxor Announces Carolinas Medical Center of Charlotte, NC Purchases BVA-100 and Blood Volume Kit Usage Increases 40%
- Daxor Announces Publication of Blood Volume Research Study By Vanderbilt University and National Institutes of Health Concerning Chronic Mountain Sickness Utilizing the BVA-100 Blood Volume Analyzer
- The Heart-Lung Center in Hawthorne, NJ Acquires Daxor BVA-100 Blood Volume Analyzer
 |
 |
User Comments (0)
RSS Feeds